Average Co-Inventor Count = 3.26
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alcon, Inc. (6 from 1,167 patents)
2. Novartis Ag (2 from 3,923 patents)
3. University of Iowa Research Foundation (2 from 902 patents)
4. Alcon Research, Ltd. (2 from 346 patents)
5. Arrowhead Pharmaceuticals, Inc. (1 from 95 patents)
6. Biochain Institute, Inc. (1 from 7 patents)
7. Biochaiv Institute, Inc. (1 from 1 patent)
13 patents:
1. 9550994 - RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
2. 9040494 - RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
3. 8173617 - RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
4. 7947660 - RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
5. 7879006 - Injection aid for anterior juxtascleral depot
6. 7807355 - Diagnostics and therapeutics for glaucoma
7. 7807363 - Superoxide dismutase-2 expression for glaucoma diagnosis
8. 7662389 - Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
9. 7598288 - Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10. 7357931 - Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
11. 7033755 - Diagnostics and therapeutics for glaucoma
12. 6723514 - Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms
13. 6265164 - Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms